DPP-4 inhibitors and severe course of illness in patients with COVID-19

Therapie. 2021 Jul-Aug;76(4):359-360. doi: 10.1016/j.therap.2021.01.051. Epub 2021 Jan 18.
[Article in French]
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • COVID-19*
  • Dipeptidyl-Peptidase IV Inhibitors*
  • Humans
  • SARS-CoV-2

Substances

  • Dipeptidyl-Peptidase IV Inhibitors